Results

Total Results: 323 records

Showing results for "malignant neoplasm".

181. HCUP-3 Nationwide Inpatient Sample for 1994: Diagnosis-Related Groups
     hcup-us.ahrq.gov/reports/natstats/94drga.htm
     October 01, 1992 - 17 Myeloproliferative Diseases and Disorders, and Poorly 473 Differentiated Neoplasms … w/ CC 11 Nervous system 9,011 0.03 4.69 7,677 neoplasms w/o … OR procedures 64 Ear, nose, mouth & 8,942 0.03 9.36 13,790 throat malignancy … digestive system 8,767 0.03 4.30 9,956 OR procedures w/o CC 172 Digestive malignancy … 57,362 0.17 8.48 12,746 w/ CC 173 Digestive malignancy 5,110

182. Statistics from the HCUP-3 Nationwide Inpatient Sample for 1993: Diagnosis-Related Groups
     hcup-us.ahrq.gov/reports/natstats/93drga.htm
     October 01, 1992 - disorders 8,225 0.02 11.90 14,318 & injuries 10 Nervous system neoplasms … 47,824 0.14 8.84 11,844 w/ CC 11 Nervous system neoplasms … OR procedures 64 Ear, nose, mouth & 9,229 0.03 8.30 12,244 throat malignancy … 9,679 0.03 4.22 8,778 OR procedures w/o CC 172 Digestive malignancy … 58,314 0.17 9.15 12,717 w/ CC 173 Digestive malignancy 6,313

183. Nis 2002 Summarystats 10Pct Sample B (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SAMPLE_B.PDF
     January 01, 2002 - cancer of skin 126 0.02 24: Cancer of breast 2252 0.29 25: Cancer of uterus 862 0.11 26: Cancer of … : Cancer of prostate 2080 0.26 30: Cancer of testis 38 0.00 31: Cancer of other male genital organs … , other Unspecified primary 220 0.03 42: Secondary malignancies 5231 0.67 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3506 0.45 46: Benign neoplasm of uterus 5578 0.71 47: Other … unspecified benign neoplasm 3552 0.45 48: Thyroid disorders 846 0.11 49: Diabetes mellitus without

184. Nis 2002 Summarystats 10Pct Sample A (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SAMPLE_A.PDF
     January 01, 2002 - cancer of skin 139 0.02 24: Cancer of breast 2343 0.30 25: Cancer of uterus 821 0.10 26: Cancer of … : Cancer of prostate 2013 0.26 30: Cancer of testis 33 0.00 31: Cancer of other male genital organs … , other Unspecified primary 204 0.03 42: Secondary malignancies 5351 0.68 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3557 0.45 46: Benign neoplasm of uterus 5501 0.70 47: Other … unspecified benign neoplasm 3605 0.46 48: Thyroid disorders 829 0.11 49: Diabetes mellitus without

185. Nis 2001 Summarystats 10Pct Sample B (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2001_SummaryStats_10PCT_SAMPLE_B.PDF
     January 01, 2001 - cancer of skin 163 0.02 24: Cancer of breast 2392 0.32 25: Cancer of uterus 729 0.10 26: Cancer of … : Cancer of prostate 1997 0.27 30: Cancer of testis 36 0.00 31: Cancer of other male genital organs … , other Unspecified primary 153 0.02 42: Secondary malignancies 5035 0.68 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3134 0.42 46: Benign neoplasm of uterus 5150 0.69 47: Other … unspecified benign neoplasm 3541 0.48 48: Thyroid disorders 753 0.10 49: Diabetes mellitus without

186. 2011Nedserratanotification022415 (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/2011NEDSErrataNotification022415.pdf
     February 01, 2015 - - 119,946 110,756 129,136 123,304 113,276 133,333 43: Malignant neoplasm without specification of site … neoplasm of uterus -- 45,619 40,210 51,027 45,386 39,992 50,781 47: Other and unspecified benign neoplasm … neoplasm of uterus -- 17.9% 15.9% 19.8% 17.7% 15.8% 19.7% 47: Other and unspecified benign neoplasm … neoplasm of uterus -- 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 47: Other and unspecified benign neoplasm … neoplasm of uterus -- 0.01% -0.01% 0.03% 0.01% -0.01% 0.03% 47: Other and unspecified benign neoplasm

187. Most Common Diagnoses and Procedures in U.S. Community Hospitals, 1996
     hcup-us.ahrq.gov/reports/natstats/commdx/table1g.htm
     February 11, 2011 - Secondary malignancies [42] 18,812 25.44 0.05 … Cancer of bronchus, lung [19] 4,338 5.87 0.01 … Other and unspecified benign neoplasm [47] 10,024 14.20 0.03 … Secondary malignancies [42] 5,706 8.08 0.02 … Other and unspecified benign neoplasm [47] 17,603 25.12 0.05

188. Nrd 2011 Maskedstats V2 Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_V2_Severity.PDF
     January 01, 2011 - electrolyte disorders 13,915,176 0 0.00 1.00 0.21 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,915,176 0 0.00 1.00 0.10 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,699 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,617 0.13% 692: Radiotherapy 1,207 0.01% 693: Chemotherapy 61,609 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,416 0.09% 710: Infectious & parasitic diseases including HIV w

189. Nrd 2010 Maskedstats Severity V2 (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Severity_V2.PDF
     January 01, 2010 - electrolyte disorders 13,907,610 0 0.00 1.00 0.20 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,907,610 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,922 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,995 0.14% 692: Radiotherapy 1,534 0.01% 693: Chemotherapy 61,552 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,680 0.09% 710: Infectious & parasitic diseases including HIV w

190. Nrd 2012 Maskedstats Severity V2 (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Severity_V2.PDF
     January 01, 2012 - electrolyte disorders 13,459,216 0 0.00 1.00 0.21 0.41 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,459,216 0 0.00 1.00 0.11 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,811 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 7,576 0.06% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 9,897 0.07% 690 … 18,144 0.13% 692: Radiotherapy 1,115 0.01% 693: Chemotherapy 58,907 0.44% 694: Lymphatic & other malignancies

191. Nrd 2013 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Severity.PDF
     January 01, 2013 - electrolyte disorders 14,325,172 0 0.00 1.00 0.22 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,325,172 0 0.00 1.00 0.11 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,987 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent of Total 692: Radiotherapy 1,114 0.01% 693: Chemotherapy 62,706 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,072 0.08% 710: Infectious & parasitic diseases including HIV w

192. Microsoft Word - APS_DRG_Def_Public_V211.doc (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V21%20Definitions%20Manual.pdf
     January 13, 2015 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS … 204 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG … PROC 366 366 MALIGNANCY, FEMALE REPRO SYSTEM 367 366 MALIGNANCY, FEMALE REPRO SYSTEM 368 368

193. Microsoft Word - covtoc.doc (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-DRGsV20DefinitionsManual.pdf
     January 13, 2015 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS … 204 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG … PROC 366 366 MALIGNANCY, FEMALE REPRO SYSTEM 367 366 MALIGNANCY, FEMALE REPRO SYSTEM 368 368

194. Nis 2011 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Severity.PDF
     January 01, 2011 - electrolyte disorders 8,023,590 0 0.00 1.00 0.20 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 8,023,590 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 6,517 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,946 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 5,098 0.06% 690 … & neoplasms of uncertain behavior 6,509 0.08% 710: Infectious & parasitic diseases including HIV w

195. G:CIRD565TQMothers able1.PDF (pdf file)
     hcup-us.ahrq.gov/reports/natstats/his96/table1.pdf
     February 11, 2011 - Benign neoplasm of uterus [46.] 222,765 0.64 $8,551 $5,702 $7,746 $10,317 3.0 0.0 … 0.0 43.8 2.16.2 Other and unspecified benign neoplasm 151,779 0.44 $13,848 $5,700 … 2.16.2.2 Benign neoplasm of colon 26,537 0.08 $13,071 $5,756 $9,785 $15,546 5.9 … 0.7 48.5 69.4 2.16.2.3 Benign neoplasm of the thyroid 12,419 0.04 $6,806 $4,265 $5,936 … $8,074 1.7 0.0 18.6 49.3 2.16.2.4 Benign neoplasm of cerebral meninges 12,413 0.04

196. HCUP Statistical Brief #30: Hospital Stays for Prostate Cancer, 2004 (pdf file)
     hcup-us.ahrq.gov/reports/statbriefs/sb30.pdf
     May 01, 2007 - TURP—a procedure involving no incision—is most commonly used to treat benign tumors of the prostate, … secondary malignancies, or metastatic cancer. … The following ICD-9-CM diagnosis codes are included in CCS category 29, Prostate Cancer: – 185 Malignant … neoplasm of prostate – 233.4 Carcinoma in situ of prostate – V10.46 Personal history of malignant … neoplasm—prostate Procedures and Clinical Classifications Software (CCS) The principal procedure

197. Cancer-Related Hospitalizations for Adults, 2017 (pdf file)
     hcup-us.ahrq.gov/reports/statbriefs/sb270-Cancer-Hospitalizations-Adults-2017.pdf
     January 01, 2017 - ■ The most common principal cancer diagnoses in 2017 were secondary malignancies, colorectal cancer … 394.3 Malignant neuroendocrine tumors 13,800 6.9 22,100 3,200 305.0 Head and neck cancers - lip and … The most common adult hospitalizations principally for cancer in 2017 were for secondary malignancies … Aggregate costs were highest for the same set of cancers: secondary malignancies ($3.5 billion), colorectal … of cancer 1,732,900 100.0 Secondary malignancies 569,800 32.9 Respiratory cancers 248,800 14.4 Non-Hodgkin

198. Present on Admission Indicators
     hcup-us.ahrq.gov/datainnovations/clinicaldata/File1_AHCA_Presentation_To_AHSS_On_POA.jsp
     August 01, 2011 - Final dx malignant neoplasm with metastasis.

199. Microsoft Word - CaseforPOAIndicator_final_060806 _2_.doc (pdf file)
     hcup-us.ahrq.gov/reports/methods/2006_1.pdf
     January 01, 2006 - For example, if a patient presents with a lump and it is diagnosed as a malignant neoplasm during the … hospitalization, the malignant neoplasm should be considered to be present on admission. … For example, “personal history of malignant neoplasm” cannot develop after admission. … Neoplasm Bronchus or Lung 11,303 11,244 99.48 1,311 1,302 99.3% 174.9 Malignant Neoplasm Breast 4,735 … 4,724 99.77 960 952 99.2% 185 Malignant Neoplasm Prostate 14,486 14,438 99.67 4,855 4,781 98.5% 250.00

200. User Guide (v2025.1) for Clinical Classifications Software Refined (CCSR) for ICD-10-CM (pdf file)
     hcup-us.ahrq.gov/toolssoftware/ccsr/DXCCSR-User-Guide-v2025-1.pdf
     November 01, 2024 - status, and Z19.2, Hormone resistant malignancy status, to CCSR category NEO071 (Malignant neoplasm … Neoplasms NEO NEO contains 78 categories specific to neoplasms, which include malignant neoplasms … such as gastrointestinal cancers, skin cancers, and breast cancer, as well as most benign neoplasms … The Neoplasms body system follows the National Cancer Institute (NCI)8 organization of cancer types … status, and Z19.2, Hormone resistant malignancy status, to CCSR category NEO071 (Malignant neoplasm